Results 221 to 230 of about 467,445 (327)

Global Trends in the Research of Ulcerative Colitis Treatments (2021-2025): A Bibliometric Review. [PDF]

Cureus
Zapatier J, Nichols E, Reddy VN, Ganti L.   +3 more
europepmc   +1 more source

A significant number of pediatric inflammatory bowel disease patients are exposed to a medication not approved by the Food and Drug Administration for pediatric use

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Inflammatory bowel disease (IBD) presents before age 20 years in ~25% of patients. Regulatory approvals of IBD medications for pediatric use are often delayed. Nevertheless, many pediatric patients receive medication not approved for pediatric use.
Courtney Rusch, Anthony J. Perkins, Steven J. Steiner, the ImproveCareNow Pediatric IBD Learning Health System   +3 more
wiley   +1 more source

Healthcare resource utilization and cost in pediatric celiac disease: A case‐control study using German insurance data

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Celiac disease (CeD) is a life‐long systemic immune‐mediated disorder. Data on burden and cost of CeD in children are scarce. We assessed healthcare resource utilization (HCRU) and cost of healthcare services of newly diagnosed children in Germany.
Sibylle Koletzko, Svitlana Schnaidt, Leonarda Serdani‐Neuhaus, Juliane Sünwoldt, Christina Dünweber, Bernd Bokemeyer   +5 more
wiley   +1 more source

Ulcerative colitis

, 2014
openaire   +1 more source

Developing IBD Outcome Effect Size Thresholds to Inform Research, Guidelines, and Clinical Decisions. [PDF]

Inflamm Bowel Dis
Gordon M, Shaban N, Sinopoulou V, Vuyyuru S, Radford S, Magro F, Armuzzi A, Peyrin-Biroulet L, Jairath V, Moran G.   +9 more
europepmc   +1 more source

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.

Gastroenterology, 2015
P. Moayyedi, M. Surette, P. Kim, J. Libertucci, M. Wolfe, Catherine Onischi, D. Armstrong, J. Marshall, Z. Kassam, W. Reinisch, Christine H. Lee   +10 more
semanticscholar   +1 more source

Vedolizumab Versus Other Biologics and the Risk of Venous Thromboembolism in Patients with Pediatric-Onset Inflammatory Bowel Diseases: A Target Trial Emulation Study. [PDF]

Paediatr Drugs
Tsai SY, Ananthakrishnan AN, Winter HS, Ma KS.   +3 more
europepmc   +1 more source

Drugs in focus: Budesonide and its role in paediatric gastrointestinal disorders

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Budesonide is a glucocorticoid with strong topical anti‐inflammatory properties and minimal systemic effects due to extensive first‐pass hepatic metabolism. It is designed for targeted delivery within the gastrointestinal (GI) tract and is available in oral and rectal formulations.
Sohail Aziz, Maria Giovanna Puoti, Amit Assa, Zrinjka Misak, Emmanuel Mas, Osvaldo Borrelli, Jernej Dolinšek, Javier Martin‐de‐Carpi, Isabelle Scheers, Christos Tzivinikos, Matjaž Homan, Caterina Strisciuglio   +11 more
wiley   +1 more source

Thymoquinone mediated hedgehog pathway activation and gut microbiota modulation in mouse colitis. [PDF]

Sci Rep
Huang X, Sun T, Xu L, Liu W, Ren Z, Ma Z, Zheng H, Li D, Wang Q, Ke X.   +9 more
europepmc   +1 more source

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Journal of Crohn's & Colitis, 2017
M. Harbord, R. Eliakim, D. Bettenworth, K. Karmiris, K. Katsanos, U. Kopylov, T. Kucharzik, T. Molnár, T. Raine, S. Sebastian, Helena Tavares de Sousa, A. Dignass, F. Carbonnel   +12 more
semanticscholar   +1 more source